Pain at Presentation and Survival in Hepatocellular Carcinoma

  • Brian I. Carr
    Address reprint requests to Brian I. Carr M.D., F.R.C.P., Ph.D., Liver Cancer Program, Kimmel Cancer Center, Thomas Jefferson University, Bluemle Building, Room 519, 233 So.10th Street, Philadelphia, PA 19107.
    Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania
    Search for articles by this author
  • Lynette Pujol
    Department of Anesthesiology, Jefferson Pain Center, Thomas Jefferson University, Philadelphia, Pennsylvania
    Search for articles by this author


      Pain is a common feature of most human cancers, including hepatocellular carcinoma (HCC). The reported frequency is quite variable, however, and the prognostic significance is not clear. In this report, we examine the incidence of pain in a large HCC database derived from unresectable patients whom we have treated and examine the prognostic and clinical correlates. We report that HCC patients with pain at presentation have a worse prognosis and adverse tumor characteristics.


      This article presents one of the first looks at correlates of pain and survival in HCC. Results of this study could inform future research and clinical investigations regarding the importance of pain at presentation in patients with HCC, which impacts qualify of life and survival.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Akechi T.
        • Okamura H.
        • Nishiwaki Y.
        • Uchitomi Y.
        Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: A longitudinal study.
        Cancer. 2001; 92: 2609-2622
        • Bartlett D.L.
        • Carr B.I.
        • Marsh J.W.
        Cancer of the Liver.
        in: DeVita V.T. Hellman S. Rosenberg S.A. Cancer: Principles and Practice of Oncology. 7th ed. Williams and Wilkins, Philadelphia, PA, Lippincott2005: 986-1009
        • Bonnetain F.
        • Paoleti X.
        • Collette S.
        • Doffoel M.
        • Bouche O.
        • Raoul J.L.
        • Rougier P.
        • Masskouri F.
        • Barbare J.C.
        • Bedenne L.
        Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials.
        Quality of Life Research. 2008; 17: 831-843
        • Butler L.D.
        • Koopman C.
        • Cordova M.J.
        • Garlan R.W.
        • DiMiceli S.
        • Spiegel D.
        Psychological distress and pain significantly increase before death in metastatic breast cancer patients.
        Psychosomatic Medicine. 2003; 65: 416-426
        • Bosch F.X.
        • Ribes J.
        • Diaz M.
        • Cleries R.
        Primary liver cancer: Worldwide Incidence and Trends.
        Gastroenterology. 2004; 127: S5-S16
        • CA
        A Cancer Journal for Clinicians.
        Cancer statistics. 2009; 59: 225-250
        • Carr B.I.
        Medical therapy of hepatocellular carcinoma, in Carr BI (ed): Hepatocellular Cancer, 2nd ed.
        Humana Press, Totowa, NJ2005 (pp 233-264)
        • Carr B.I.
        • Buch S.C.
        • Kondragunta V.
        • Pacoska P.
        • Branch R.A.
        Tumor and liver determinants of prognosis in unresectable HCC: a case cohort study.
        J Gastroenterol Hepatol. 2008; 23: 1259-1266
        • Chung J.W.
        • Yang J.C.
        • Wong T.K.
        The significance of pain among Chinese patients with cancer in Hong Kong.
        Acta Anaesthesiologica Sinica. 1999; 34: 9-14
        • Dharma-Wardene M.
        • Au H.J.
        • Hanson J.
        • Dupere D.
        • Hewitt J.
        • Feeny D.
        Baseline FACT-G score is a predictor of survival for advanced lung cancer.
        Qual Life Res. 2004; 13: 1209-1216
        • Edwards B.K.
        • Brown M.L.
        • Wingo P.A.
        • Howe H.L.
        • Nard E.
        • Ries L.A.G.
        • Schrag D.
        • Jamison P.M.
        • Jemal A.
        • Wu X.C.
        • Friedman C.
        • Harlan L.
        • Warren J.
        • Anderson R.N.
        • Pickle L.W.
        Annual Report to the Nation on the Status of Cancer, 1975-2002, Featuring Population-Based Trends in Cancer Treatment.
        J Natl Cancer Inst. 2005; 97: 1407-1427
        • Nomura F.
        • Ohnishi K.
        • Tanabe Y.
        Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients.
        Cancer. 1989; 64: 1700-1707
        • Okuda K.
        • Ohtsuki T.
        • Obata H.
        • Tomimatsu M.
        • Okazaki N.
        • Hasegawa H.
        • Nakajima Y.
        • Ohnishi K.
        Natural history of hepatocellular carcinoma and prognosis in relation to treatment.
        Cancer. 1985; 56: 918-928
        • Poon R.T.
        • Fan S.T.
        • Yu W.C.
        • Lam B.K.
        • Chan F.Y.
        • Wong J.
        A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma.
        Arch Surg. 2001; 136: 693-699
        • Pujol L.
        • Carr B.
        Pain at presentation and survival in hepatocellular carcinoma.
        [abstract] J Pain. 2009; 10: S4
      1. Quinten C, Coens C, Mauer M, Comte S, Sprangers MAG, Cleeland C, Osoba D, Bjordal, K, Bottomley: A. baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Available at: 10:865-871, 2009. Accessed August 3, 2009

      2. SPSS for Windows, release 16.0.
        SPSS Inc., Chicago, IL2007
        • Steel J.L.
        • Chopra K.
        • Olek M.C.
        • Carr B.I.
        Health-related quality of life: Hepatocellular carcinoma, chronic liver disease, and the general population.
        Qual Life Res. 2007; 16: 203-215
        • Steel J.L.
        • Eton D.T.
        • Cella D.
        • Olek M.C.
        • Carr B.I.
        Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma.
        Ann Oncol. 2006; 17: 304-312
        • Steel J.
        • Geller D.
        • Gamblin C.
        • Olek M.
        • Carr B.I.
        Depression, immunity, and survival in patients with hepatobiliary carcinoma.
        J Clin Oncol. 2007; 25: 2397-2405
        • Sun V.
        • Ferrell B.
        • Juarez G.
        • Wagman L.D.
        • Yen Y.
        • Chung V.
        Symptom concerns and quality of life in hepatobiliary cancers.
        Oncol Nurs Forum. 2008; 35: E45-E52
        • Yeo W.
        • Mo F.K.
        • Koh J.
        • Chan A.T.
        • Leung T.
        • Hui P.
        • Chan L.
        • Tang A.
        • Lee J.J.
        • Mok T.X.
        • Lai P.B.
        • Johnson P.J.
        • Zee B.
        Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
        Ann Oncol. 2006; 17: 1037-1038
        • Zibari G.B.
        • Riche A.
        • Zizzi H.C.
        • McMillan R.W.
        • Aultman D.F.
        • Boykin K.N.
        • Gonzalez E.
        • Nandy I.
        • Dies D.F.
        • Gholson C.F.
        • Holcombe R.F.
        • McDonald J.C.
        Surgical and nonsurgical management of primary and metastatic liver tumors.
        Am Surg. 1998; 64: 211-220